advertisement

---

Kim YC 3

Showing records 1 to 3 | Display all abstracts from Kim YC

98066 A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells
Kim YC
Drug delivery and translational research 2022; 12: 826-837

---

98774 Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
Lee YH; Kim YC
Scientific reports 2022; 12: 2051

---

98066 A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells
Hsueh HT; Shin MD; Berlinicke CA; Han H; Anders NM; Hemingway A; Leo KT; Chou RT; Kwon H; Appell MB; Rai U; Kolodziejski P; Eberhart C; Pitha I; Zack DJ; Hanes J; Ensign LM
Drug delivery and translational research 2022; 12: 826-837

---